Celltrion Pharm

068760.KQ

38.74 USD

0.73

+1.92%

Overview

Last close

38.74 usd

Market cap

1.68B usd

52 week high

82.04 usd

52 week low

30.18 usd

Target price

98.12 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.455

Price/Book Value

5.5642

Enterprise Value

1.71B usd

EV/Revenue

4.6771

EV/EBITDA

32.8117

Key financials

Revenue TTM

198.22M usd

Gross Profit TTM

58.33M usd

EBITDA TTM

30.88M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

538.06M usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.